Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/10397
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Muhammad, Syamel | - |
dc.contributor.author | Setiawan, Muhammad Rudy | - |
dc.date.accessioned | 2025-06-10T03:05:39Z | - |
dc.date.available | 2025-06-10T03:05:39Z | - |
dc.date.issued | 2024-04 | - |
dc.identifier.citation | Research Article | en_US |
dc.identifier.uri | http://localhost:8080/xmlui/handle/123456789/10397 | - |
dc.description.abstract | Objective: To determine serum CA-125 examination as predictor in predicting the resectability of advanced ovarian cancer at dr. M. Djamil Padang Methods: The research sample was obtained using a consecutive sampling technique, wherein samples were collected one by one within the specifi ed timeframe until the required sample size was achieved. Results: The mean CA-125 level among respondents was 589.66 U/mL with a standard deviation of 841.55 U/mL. The study also revealed that a CA-125 cutoff value of 337.5 U/mL demonstrated high sensitivity (92.31%) and specifi city (90.90%) in predicting the resectability of ovarian cancer. Conclusion: Serum CA-125 examination shows a promising result in predicting the resectability of advanced ovarian cancer at dr. M. Djamil Padang | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | Indones J Obstet Gynecol | en_US |
dc.subject | CA-125 | en_US |
dc.subject | consecutive sampling technique | en_US |
dc.subject | ovarian cancer | en_US |
dc.title | CA-125 Examination as a Predictor the Resectability of Advanced Stage of Ovarian Cancer | en_US |
dc.type | Article | en_US |
Appears in Collections: | Volume 12 No 2 2024 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.